Rinkey Investments Agenus Inc Transaction History

Rinkey Investments

  • $307 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$2.35 - $3.47 $1,175 - $1,735
-500 Closed
0 $0
Q4 2021

Feb 17, 2022
BUY
$2.92 - $5.74 $1,460 - $2,870
500 New
500 $1,000

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Rinkey Investments Portfolio

Follow Rinkey Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rinkey Investments, based on Form 13F filings with the SEC.

News

Stay updated on Rinkey Investments with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email